Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMPS
CMPS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMPS News
Positive COMP360 Data Boosts Stock Price
18h ago
stocktwits
Compass Pathways Releases New Data on COMP360 for Treatment-Resistant Depression
1d ago
seekingalpha
Evercore ISI Upgrades Compass Pathways to Outperform with Price Target Raised to $21
26m ago
seekingalpha
Compass Pathways' COMP360 Shows Strong Phase 3 Data for TRD
1d ago
stocktwits
COMP360 Shows Breakthrough Progress in Treatment-Resistant Depression
1d ago
Newsfilter
Compass Pathways Grants Equity Awards to New Employees
6d ago
Newsfilter
Rapid Growth in Major Depressive Disorder Treatment Market
Jun 30 2026
Newsfilter
Kailera Appoints New Chief Corporate Affairs Officer
Jun 29 2026
Globenewswire
Helus Pharma's HLP003 Phase 3 Trial Enrollment Surpasses 86%
Jun 26 2026
PRnewswire
Helus Pharma's HLP003 Phase 3 Trial Surpasses 86% Enrollment
Jun 26 2026
Newsfilter
Definium Reports Positive Trial Results, Stock Soars
Jun 23 2026
stocktwits
Compass Pathways Grants Equity Awards to New Employees
Jun 05 2026
Newsfilter
Trump Pushes Psychedelic Research for Mental Illness Treatment
May 31 2026
CNBC
Compass Pathways Appoints New Board Member
May 28 2026
Newsfilter
Compass Pathways to Attend Jefferies Global Healthcare Conference
May 26 2026
Newsfilter
FDA Leadership Change Boosts Psychedelic Drug Prospects
May 18 2026
stocktwits
Show More News
